首页/数据集/PFKFB3 attenuates cisplatin-induced ferroptosis in gastric cancer via dephosphorylation of SLC7A11/xCT

PFKFB3 attenuates cisplatin-induced ferroptosis in gastric cancer via dephosphorylation of SLC7A11/xCT

Mendeley Data2024-01-01 更新2026-04-09 收录

铁死亡调控

肿瘤耐药机制

数据链接：

https://data.mendeley.com/datasets/zwn8w8x42c 数据链接链接失效反馈

官方服务：

资源简介：

the original, unprocessed data of PFKFB3 attenuates cisplatin-induced ferroptosis in gastric cancer via dephosphorylation of SLC7A11/xCT

应用场景：

创建时间：

2024-01-01

肿瘤抑制机制

铁死亡调控

The tumor suppressor protein p53 suppresses cancer by regulating processes such as apoptosis, cell cycle arrest, senescence, and ferroptosis. Whereas numerous p53 target genes have been identified, o

NIAID Data Ecosystem50

Suppression of adaptive responses to targeted cancer therapy by transcriptional repression [RNA-seq]. Homo sapiens

肿瘤耐药机制

转录组药物响应

Large-scale genomic profiling efforts have facilitated the characterization of molecular alterations in cancers and aided the development of targeted kinase inhibitors for a wide array of cancer types

NIAID Data Ecosystem50

Upregulated stromal EGFR and vascular remodeling in human NSCLC murine models (xenografts) of VEGF inhibitor resistance

肿瘤耐药机制

EGFR信号通路

The mechanisms by which tumors develop resistance to angiogenesis inhibitors, and the relative contributions of tumor cells and stroma to resistance, are not completely understood. We developed three

NIAID Data Ecosystem30

Reversing Melanoma Cross-Resistance to BRAF and MEK Inhibitors by Co-Targeting the AKT/mTOR Pathway

肿瘤耐药机制

信号通路靶向治疗

BackgroundThe sustained clinical activity of the BRAF inhibitor vemurafenib (PLX4032/RG7204) in patients with BRAFV600 mutant melanoma is limited primarily by the development of acquired resistance le

Figshare2016-01-18 更新50

Clinical Profiling of BCL-2 Family Members in the Setting of BRAF Inhibition Offers a Rationale for Targeting De Novo Resistance Using BH3 Mimetics

肿瘤耐药机制

药物联合治疗

While response rates to BRAF inhibitiors (BRAFi) are high, disease progression emerges quickly. One strategy to delay the onset of resistance is to target anti-apoptotic proteins such as BCL-2, known

Figshare2016-01-15 更新40

PFKFB3 attenuates cisplatin-induced ferroptosis in gastric cancer via dephosphorylation of SLC7A11/xCT

资源简介：

相关数据集